Lataa...
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
BACKGROUND: Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor, has been proposed to mitigate the cytokine storm syndrome associated with severe COVID-19. We aimed to investigate the association between tocilizumab exposure and hospital-related mortality among patients re...
Tallennettuna:
| Julkaisussa: | Lancet Rheumatol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Ltd.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7428303/ https://ncbi.nlm.nih.gov/pubmed/32838323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(20)30277-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|